Lupin Limited has informed the Exchange regarding a press release dated November 10, 2023, titled "Lupin and Amman Pharma Sign Exclusive Licensing and Supply Agreement forRanibizumab Biosimilar.".
Press Release Nov 10 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Lupin
- Press Release Nov 08 2023
- Press Release Nov 07 2023
- Press Release Nov 03 2023
- Press Release Nov 02 2023
- Press Release Oct 31 2023
Later from Lupin
- Press Release Nov 17 2023
- Press Release Nov 21 2023
- Press Release Nov 23 2023
- Press Release Dec 01 2023
- Lupin Limited Press Release Dec 06 2023
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin